The report also mentioned that phase 2 results do not permit efficacy assessments and further corroboration with phase 3 safety results was required. Bharat Biotech's Covaxin Safe But Need Phase 3 Results to Assess Effectiveness, Says Lancet
The report also mentioned that phase 2 results do not permit efficacy assessments and further corroboration with phase 3 safety results was required. Bharat Biotech's Covaxin Safe But Need Phase 3 Results to Assess Effectiveness, Says Lancet
No comments:
Post a Comment